Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis

Lookup NU author(s): Professor Cliff Brass, Professor Arun Sanyal, Professor Quentin AnsteeORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© 2023. The Author(s). BACKGROUND: Standardized measures for evaluating patients' experiences with nonalcoholic steatohepatitis (NASH) and their perceived changes with treatment in clinical trials have been limited. To meet this need, a patient-reported outcome (PRO) measure, NASH-CHECK, was developed to evaluate symptoms and health-related quality of life for patients with NASH. The objective of this study was to conduct a quantitative evaluation of the psychometric properties of NASH-CHECK. METHODS: The study used data from a phase 2, randomized controlled trial of adult patients with NASH (NCT02855164). Analyses were conducted to determine the optimal scoring of NASH-CHECK and to evaluate reliability, construct validity, and ability to detect change in NASH-CHECK scale scores. RESULTS: Data were available for 253 patients with NASH (61% female; mean [standard deviation] age = 53 [12] years). Following initial item-level analyses, including correlations and exploratory factor analysis, three items were removed from the measure. Confirmatory factor analysis supported the formation of four multi-item scales (Cognitive Symptoms, Activity Limitations, Social Impact, and Emotional Impact) and five single-item scales (Abdominal Pain, Abdominal Bloating, Fatigue, Sleep, and Itchy Skin). Psychometric analyses of the final NASH-CHECK scales provided support for their internal reliability, test-retest reliability, construct validity, and ability to detect change. CONCLUSION: The results support NASH-CHECK as a reliable, valid, and responsive measure to assess patients' perspectives of symptoms and the health-related quality of life impact of NASH in clinical trials and in routine practice.


Publication metadata

Author(s): Twiss J, Whalley D, Doward L, Balp M-M, Brass CA, Cryer D, Sanyal A, Anstee QM

Publication type: Article

Publication status: Published

Journal: Journal of Patient-Reported Outcomes

Year: 2023

Volume: 7

Issue: 1

Online publication date: 14/07/2023

Acceptance date: 04/05/2023

Date deposited: 19/12/2023

ISSN (electronic): 2509-8020

Publisher: SpringerOpen

URL: https://doi.org/10.1186/s41687-023-00589-5

DOI: 10.1186/s41687-023-00589-5

PubMed id: 37450086


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
777377European Commission

Share